VSee Health, Inc. issued a shareholder letter on March 6, 2025, from Co-CEOs Milton Chen and Imo Aisiku, highlighting the company's 2024 achievements and a strong growth outlook for 2025. The letter emphasized VSee's momentum in AI-driven telehealth since its Nasdaq listing in mid-2024.
The letter detailed several key accomplishments, including a multi-year government contract with $6 million allocated for the first year, a strategic partnership with AbundaBox to launch AbundaLife™ for health record management, and an agreement with Ava Robotics for telepresence solutions in intensive care. It also mentioned a partnership with LanguageLine Solutions for multilingual care.
Recent contract announcements were also highlighted, such as a $560,000 contract with a major oncology network, a contract with a top-five kidney care provider showing an 88% increase in telehealth call completion rates, a $2 million contract renewal for neurocritical care with robotics expansion, and a $340,000 contract for an AI-enabled EHR platform. The company expressed confidence in 2025 being a record-breaking year due to its growing pipeline and strategic positioning.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.